Medicare Enrolled
Dr. Sobia Nabeel, M.D
Hematology & Oncology · Arlington, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nabeel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nabeel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nabeel
Dr. Sobia Nabeel is a hematology & oncology specialist in Arlington, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Nabeel performed 2,469 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Nabeel received a total of $2,825 from 32 pharmaceutical and/or device companies across 97 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nabeel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 42% volume in TX
$2,825 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,469
Medicare services
Top 42% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
452 | $0 | $7 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
319 | $8 | $10 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
290 | $8 | $22 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
225 | $10 | $29 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
166 | $95 | $219 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 143 | $127 | $1,043 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
91 | $102 | $325 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
78 | $135 | $295 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
65 | $10 | $54 |
| PSA test (prostate cancer screening) | 58 | $18 | $51 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
51 | $25 | $71 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
51 | $22 | $80 |
| New patient office visit, complex (60-74 min) | 51 | $146 | $420 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
50 | $25 | $86 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $66 | $150 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
39 | $13 | $38 |
| Iron level test | 37 | $6 | $18 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
37 | $9 | $24 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
36 | $29 | $75 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
32 | $16 | $48 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
30 | $12 | $51 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
23 | $15 | $42 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
21 | $48 | $145 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
20 | $6 | $17 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
15 | $5 | $15 |
| Manual red blood cell count A laboratory test that manually counts the number of red blood cells in a blood sample. |
13 | $4 | $12 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
13 | $3 | $8 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
12 | $14 | $41 |
| HIV-1 antigen and HIV-1/2 antibody test A laboratory test using immunoassay techniques to detect HIV-1 antigens and antibodies for both HIV-1 and HIV-2. |
11 | $24 | $68 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
6.6% high complexity
24.2% medium
69.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,825
Total received (2018-2024)
Avg $404/year across 7 years
Bottom 47% in TX for hematology & oncology
32
Companies
97
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$116
2023
$691
2022
$1,003
2021
$829
2020
$21
2019
$53
2018
$113
Payments by company (2024)
Janssen Biotech, Inc.
$116
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$767
PFIZER INC.
$219
Novartis Pharmaceuticals Corporation
$210
Lilly USA, LLC
$192
Astellas Pharma US Inc
$182
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Merck Sharp & Dohme Corporation
$103
Amgen Inc.
$94
Gilead Sciences, Inc.
$82
E.R. Squibb & Sons, L.L.C.
$75
GENZYME CORPORATION
$65
TerSera Therapeutics LLC
$53
Rigel Pharmaceuticals, Inc.
$52
AstraZeneca Pharmaceuticals LP
$51
Eisai Inc.
$48
EISAI INC.
$47
Celgene Corporation
$40
PUMA BIOTECHNOLOGY, INC.
$39
Incyte Corporation
$39
Sobi, Inc
$33
Genentech USA, Inc.
$33
Regeneron Healthcare Solutions, Inc.
$26
Octapharma USA, Inc.
$26
Kite Pharma, Inc.
$25
MorphoSys, US Inc.
$24
Dendreon Pharmaceuticals LLC
$21
GlaxoSmithKline, LLC.
$20
Seagen Inc.
$19
Myovant Sciences Inc.
$19
Ipsen Biopharmaceuticals, Inc
$19
ARRAY BIOPHARMA INC
$18
ABBVIE INC.
$17
Top 3 companies account for 42.3% of all-time payments
Associated products mentioned in payments ›
ABECMA · BOSULIF · BRAFTOVI · DOPTELET · ELITEK · ERLEADA · Halaven · IBRANCE · IMBRUVICA · IMFINZI · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUPRON DEPOT · LYNPARZA · Lenvima · MONJUVI · NERLYNX · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPDIVO · ORGOVYX · PADCEV · PROVENGE · Perjeta · Prolia · REBLOZYL · RYBREVANT · Revlimid · SOMATULINE DEPOT · TUKYSA · Tavalisse · Trodelvy · VERZENIO · XALKORI · XTANDI · ZEJULA · ZOLADEX
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
117
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
USMD HOSPITAL AT ARLINGTON L P
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nabeel is a mixed practice specialist, with moderate Medicare volume, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nabeel experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Nabeel performed 452 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Nabeel receive payments from pharmaceutical companies?
Yes. Dr. Nabeel received a total of $2,825 from 32 companies across 97 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nabeel's costs compare to other hematology & oncology specialists in Arlington?
Dr. Nabeel's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nabeel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Arlington
Browse hematology & oncology specialists in Arlington ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology